Literature DB >> 2376111

Influence of infusion method on serum tobramycin concentrations in adults with cystic fibrosis.

R A Pleasants1, D M Williams, W E Waltner, M R Knowles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2376111

Source DB:  PubMed          Journal:  Clin Pharm        ISSN： 0278-2677


× No keyword cloud information.
  3 in total

Review 1.  Intravenous infusion conditions. Implications for pharmacokinetic monitoring.

Authors:  M C Nahata
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

2.  An in vivo assessment of the tobramycin/ticarcillin interaction in cystic fibrosis patients.

Authors:  G W Roberts; R L Nation; A O Jarvinen; A J Martin
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

3.  Minimisation of aminoglycoside toxicity in patients with cystic fibrosis.

Authors:  P J Wood; L L Ioannides-Demos; S C Li; T J Williams; B Hickey; W J Spicer; R E Hooper; A J McLean
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.